SmithKline Beecham Pharmaceuticals Co. – Trademark Portfolio
Entity Type: 03
SmithKline Beecham Pharmaceuticals Co. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include TAGAMET HB, TAGAMET 200, and TAGAMET HB 200. The owner is based in Carolina, PR.
P.O. Box 3920
Carolina, PR 00630
Showing of trademarks Trademarks
Trademark Classifications
SmithKline Beecham Pharmaceuticals Co.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SmithKline Beecham Pharmaceuticals Co. have?
SmithKline Beecham Pharmaceuticals Co. has 21 U.S. trademarks filed with the USPTO. Of these, 5 registered, 9 abandoned, 7 cancelled.
What trademark classes does SmithKline Beecham Pharmaceuticals Co. file in?
SmithKline Beecham Pharmaceuticals Co. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SmithKline Beecham Pharmaceuticals Co.'s most well-known trademarks?
SmithKline Beecham Pharmaceuticals Co.'s registered trademark portfolio includes well-known marks such as TAGAMET HB, TAGAMET 200, and TAGAMET HB 200. These are among 5 currently registered trademarks in the portfolio.
What is SmithKline Beecham Pharmaceuticals Co.'s trademark registration success rate?
SmithKline Beecham Pharmaceuticals Co. has a 24% trademark registration rate, with 5 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.